Joshua H. Soven is a partner in the Washington, D.C. office of Gibson, Dunn & Crutcher LLP. Mr. Soven's practice focuses on government antitrust investigations, antitrust litigation, and counseling on competition issues. He represents clients before the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission, and in the federal courts.
Since joining Gibson Dunn in 2012, Mr. Soven has served as lead global antitrust counsel for strategic transactions for a range of prominent companies, including AECOM, Avnet, Francisco Partners, Hewlett-Packard, LinkedIn, Matson, Norbord, Retalix, Southern Power, St. Jude Medical, and Tenet Healthcare. He recently represented LinkedIn in its $26 billion sale to Microsoft and St. Jude Medical in its $25 billion sale to Abbott Laboratories. Mr. Soven is presently defending BNSF in a multibillion-dollar antitrust class action.
Mr. Soven is ranked as a leading antitrust lawyer by Chambers USA: America's Leading Lawyers for Business, The International Who's Who of Competition Lawyers, and Best Lawyers. In the last two years, Chambers USA has written that clients give Mr. Soven "the 'highest marks' for his work on litigation and government investigations." Chambers also described Mr. Soven as a "fantastic" antitrust lawyer who "brings deep prior experience in senior positions at both the FTC and DOJ to his highly regarded antitrust practice. . . Sources praise his creative and strategic solutions and comment that he understands the nuances of antitrust doctrine." The National Law Journal has recognized Mr. Soven as an antitrust "Trailblazer" for excellence in antitrust merger clearance.
Mr. Soven has served in high-level positions at both U.S. antitrust agencies. He was Chief of the Litigation I Section of the Antitrust Division of the U.S. Department of Justice. In this role, he directed all of the Antitrust Division's investigations and litigation challenges in the health insurance, consumer products, packaging, beer, and dairy sectors, including the successful litigation challenge in United States v. Blue Cross Blue Shield of Michigan (E.D. Mich. 2010). He also handled the investigation of and negotiation of divestiture agreements for the following transactions: International Paper/Temple-Inland; Graphic Packaging/Altivity Packaging; Blue Cross Blue Shield of Montana/New West Health Services; UnitedHealth Group/Sierra Health Services; InBev/Anheuser-Busch; and Grupo Bimbo/Sara Lee. In addition, Mr. Soven served as a trial attorney in the Antitrust Division's Networks & Technology Enforcement Section where he led investigations in the software, electronic payment system, and financial services sectors, including the Antitrust Division's successful litigation challenge to the First Data/Concord debit card networks merger, United States v. First Data (D.D.C. 2003).
From 2004 to 2007, Mr. Soven was an Attorney Advisor to Federal Trade Commission Chairman Deborah Platt Majoras, where he advised the Chairman on antitrust investigations in many industries, including pharmaceuticals, hospitals, media, oil & gas, and semiconductors.
Mr. Soven has extensive experience handling matters involving antitrust reviews in multiple jurisdictions, and years of experience working with competition officials throughout the world. While at the Federal Trade Commission, Mr. Soven regularly represented the United States at the Organization for Economic Cooperation and Development and the International Competition Network. He has lectured on antitrust issues in China and Europe.
Mr. Soven is an editor of the ABA's Antitrust Magazine and a former editor of the ABA's Antitrust Law Journal. He has spoken at dozens of conferences on antitrust issues and served as a lecturer at the Kellogg School of Management at Northwestern University, where he co-taught a course on strategy and competition policy in the health care sector.
Mr. Soven clerked for Judge Robert G. Doumar of the U.S. District Court for the Eastern District of Virginia.
- Hewlett Packard Enterprise in the $4 billion sale of its information technology services business to Computer Sciences Corporation.
- LinkedIn in its $26 billion sale to Microsoft.
- St. Jude Medical in its $25 billion sale to Abbott Laboratories.
- Marriott in its $13 billion acquisition of Starwood.
- Southern Power in its $2 billion joint venture with Kinder Morgan.
- Southern Power in its $8 billion acquisition of AGL Resources.
- Norbord in its $650 million acquisition of Ainsworth. Obtained unconditional clearance following a Justice Department Second Request investigation.
- AECOM in its $6 billion acquisition of URS.
- Tenet Healthcare in its $2 billion acquisition of United Surgical Partners International.
- Tenet Healthcare in its acquisition of Emanuel Medical Center. Obtained unconditional clearance following an FTC Second Request investigation.
- Ameristar in its $2.8 billion sale to Pinnacle Entertainment.
- Hewlett-Packard in its sale of mobile device patents to Qualcomm.
- A large industrial company in its $1.7 billion acquisition of a competitor in the paper-based consumer products sector. Obtained unconditional clearance following a Justice Department Second Request investigation.
- Recordati in its acquisition of rare-disease products from Lundbeck.
- Retalix in its $650 million sale to NCR.
- Representing BNSF Railway in In re Rail Freight Fuel Surcharge Antitrust Litigation (D.D.C.).
- Representing Clorox in Woodman's Food Market v. The Clorox Company (W.D. Wis.)
- University of Virginia School of Law – J.D., 1991
- University of Pennsylvania – B.A., Economics and History, summa cum laude, 1988
District of Columbia